References
- World Health Organization. Public Health Action for Prevention of Suicide: A Framework. 2012
- Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance--United States, 2007. Morbidity Mortality Weekly Rep Surveillance Summaries. 2008;57(4):1–131.
- Yard E, Radhakrishnan L, Ballesteros MF, et al. Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021. MMWR Morb Mortal Wkly Rep. 2021;70(24):888–894. doi:10.15585/mmwr.mm7024e1
- Barbeito S, Vega P, Sánchez-Gutiérrez T, Becerra JA, González-Pinto A, Calvo A. A systematic review of suicide and suicide attempts in adolescents with psychotic disorders. Schizophr Res. 2021;235:80–90. doi:10.1016/j.schres.2021.07.029
- DeVylder JE, Lukens EP, Link BG, Lieberman JA. Suicidal ideation and suicide attempts among adults with psychotic experiences: data from the Collaborative Psychiatric Epidemiology Surveys. JAMA Psychiatry. 2015;72(3):219–225. doi:10.1001/jamapsychiatry.2014.2663
- Deisenhammer EA, Ing CM, Strauss R, Kemmler G, Hinterhuber H, Weiss EM. The duration of the suicidal process: how much time is left for intervention between consideration and accomplishment of a suicide attempt? J Clin Psychiatry. 2009;70(1):19–24. doi:10.4088/JCP.07m03904
- Nock M, Green J, Hwang I, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA psychiatry. 2013;70(3):300–310. doi:10.1001/2013.jamapsychiatry.55
- O’Connor R, Nock M. The psychology of suicidal behaviour. Lancet Psychiatry. 2014;1(1):73–85. doi:10.1016/s2215-0366(14)70222-6
- Afifi T, Enns M, Cox B, Asmundson G, Stein M, Sareen J. Population attributable fractions of psychiatric disorders and suicide ideation and attempts associated with adverse childhood experiences. Am J Public Health. 2008;98(5):946–952. doi:10.2105/ajph.2007.120253
- Franklin J, Ribeiro J, Fox K, et al. Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull. 2017;143(2):187–232. doi:10.1037/bul0000084
- Köhler C, Freitas T, Stubbs B, et al. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: systematic Review and Meta-Analysis. Mol Neurobiol. 2018;55(5):4195–4206. doi:10.1007/s12035-017-0632-1
- Hernández M, Mendieta D, Martínez-Fong D, et al. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. Eur Neuropsychopharmacology. 2008;18(12):917–924. doi:10.1016/j.euroneuro.2008.08.001
- Gałecki P, Talarowska M. Inflammatory theory of depression. Psychiatr Pol. 2018;52(3):437–447. doi:10.12740/pp/76863
- Ucuz İ, Kayhan Tetik B. Can suicide behavior and seasonality of suicide be predicted from inflammatory parameters in adolescents? Med Hypotheses. 2020;143:110061. doi:10.1016/j.mehy.2020.110061
- Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95–98. doi:10.1093/qjmed/hcab007
- Rafiei S, Raoofi S, Pashazadeh Kan F, et al. Global prevalence of suicide in patients living with HIV/AIDS: a systematic review and meta-analysis. J Affect Disord. 2023;323:400–408. doi:10.1016/j.jad.2022.11.061
- Facanali CBG, Sobrado Junior CW, Fraguas Junior R, et al. The relationship of major depressive disorder with Crohn’s disease activity. Clinics. 2023;78:100188. doi:10.1016/j.clinsp.2023.100188
- Ferencova N, Visnovcova Z, Ondrejka I, et al. Evaluation of Inflammatory Response System (IRS) and Compensatory Immune Response System (CIRS) in Adolescent Major Depression. J Inflamm Res. 2022;15:5959–5976. doi:10.2147/jir.S387588
- Toenders YJ, Laskaris L, Davey CG, et al. Inflammation and depression in young people: a systematic review and proposed inflammatory pathways. Mol Psychiatry. 2022;27(1):315–327. doi:10.1038/s41380-021-01306-8
- Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: a meta-analysis. J Affect Disord. 2020;277:940–948. doi:10.1016/j.jad.2020.09.025
- Hu J, Wang L, Fan K, et al. The Association Between Systemic Inflammatory Markers and Post-Stroke Depression: a Prospective Stroke Cohort. Clin Interv Aging. 2021;16:1231–1239. doi:10.2147/cia.S314131
- Mazza M, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600. doi:10.1016/j.bbi.2020.07.037
- Benedetti F, Palladini M, Paolini M, et al. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study. Brain Behavior Immunity. 2021;18:100387. doi:10.1016/j.bbih.2021.100387
- Velasco Á, Rodríguez-Revuelta J, Olié E, et al. Neutrophil-to-lymphocyte ratio: a potential new peripheral biomarker of suicidal behavior. Eur Psychiatry. 2020;63(1):e14. doi:10.1192/j.eurpsy.2019.20
- Alacreu-Crespo A, Guillaume S, Richard-Devantoy S, Cazals A, Olié E, Courtet P. Clinical Dimensions Associated With Psychological Pain in Suicidal Patients: one-Year Follow-up Study. J Clin Psychiatry. 2022;83(2). doi:10.4088/JCP.21m14065
- Tomaz VS, Chaves Filho AJM, Cordeiro RC, et al. Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression. J Affect Disord. 2020;268:188–200. doi:10.1016/j.jad.2020.03.022
- Mello BSF, Chaves Filho AJM, Custódio CS, et al. Doxycycline at subantimicrobial dose combined with escitalopram reverses depressive-like behavior and neuroinflammatory hippocampal alterations in the lipopolysaccharide model of depression. J Affect Disord. 2021;292:733–745. doi:10.1016/j.jad.2021.05.083
- Brønnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(10):1457–1459. doi:10.1136/jnnp.2004.056747
- Zakeri Z, Shakiba M, Narouie B, Mladkova N, Ghasemi-Rad M, Khosravi A. Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int. 2012;32(5):1179–1187. doi:10.1007/s00296-010-1791-9
- Vasupanrajit A, Jirakran K, Tunvirachaisakul C, Maes M. Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: a systematic review and meta-analysis. J Affect Disord. 2021;295:80–92. doi:10.1016/j.jad.2021.08.015
- Li W, Ali T, Zheng C, et al. Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes. Mol Psychiatry. 2022;27(2):1047–1058. doi:10.1038/s41380-021-01327-3
- Vai B, Mazza MG, Cazzetta S, et al. Higher Interleukin 13 differentiates patients with a positive history of suicide attempts in major depressive disorder. J Affective Disorders Reports. 2021;6:100254. doi:10.1016/j.jadr.2021.100254
- Porter GA, O’Connor JC. Brain-derived neurotrophic factor and inflammation in depression: pathogenic partners in crime? World j Psychiatry. 2022;12(1):77–97. doi:10.5498/wjp.v12.i1.77
- Keaton SA, Madaj ZB, Heilman P, et al. An inflammatory profile linked to increased suicide risk. J Affect Disord. 2019;247:57–65. doi:10.1016/j.jad.2018.12.100
- Oh KY, Van Dam NT, Doucette JT, Murrough JW. Effects of chronic physical disease and systemic inflammation on suicide risk in patients with depression: a hospital-based case-control study. Psychol Med. 2020;50(1):29–37. doi:10.1017/s0033291718003902
- Serafini G, Parisi VM, Aguglia A, et al. A Specific Inflammatory Profile Underlying Suicide Risk? Systematic Review of the Main Literature Findings. Int J Environ Res Public Health. 2020;17(7):2393. doi:10.3390/ijerph17072393
- Black C, Miller B. Meta-Analysis of Cytokines and Chemokines in Suicidality: distinguishing Suicidal Versus Nonsuicidal Patients. Biol Psychiatry. 2015;78(1):28–37. doi:10.1016/j.biopsych.2014.10.014
- Shinko Y, Otsuka I, Okazaki S, et al. Chemokine alterations in the postmortem brains of suicide completers. J Psychiatr Res. 2020;120:29–33. doi:10.1016/j.jpsychires.2019.10.008
- Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry. 2012;71(1):15–21. doi:10.1016/j.biopsych.2011.09.023
- Rohleder N, Miller GE. Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity. Brain Behav Immun. 2008;22(5):709–716. doi:10.1016/j.bbi.2007.10.012
- Gill H, El-Halabi S, Majeed A, et al. The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: a Systematic Review. J Affect Disord. 2020;272:1–7. doi:10.1016/j.jad.2020.03.145
- Mac Giollabhui N, Ng TH, Ellman LM, Alloy LB. The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression. Mol Psychiatry. 2021;26(7):3302–3314. doi:10.1038/s41380-020-00867-4
- Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71(10):1121–1128. doi:10.1001/jamapsychiatry.2014.1332
- Neurauter G, Schröcksnadel K, Scholl-Bürgi S, et al. Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab. 2008;9(7):622–627. doi:10.2174/138920008785821738
- Dantzer R, Walker AK. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm. 2014;121(8):925–932. doi:10.1007/s00702-014-1187-1
- Tilleux S, Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res. 2007;85(10):2059–2070. doi:10.1002/jnr.21325
- Ida T, Hara M, Nakamura Y, Kozaki S, Tsunoda S, Ihara H. Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci Lett. 2008;432(3):232–236. doi:10.1016/j.neulet.2007.12.047
- Takaki J, Fujimori K, Miura M, Suzuki T, Sekino Y, Sato K. L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflammation. 2012;9(1):275. doi:10.1186/1742-2094-9-275
- Felger JC. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders. Curr Neuropharmacol. 2018;16(5):533–558. doi:10.2174/1570159x15666171123201142
- Cunnington C, Channon KM. Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart. 2010;96(23):1872–1877. doi:10.1136/hrt.2009.180430
- Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998;273(40):25804–25808. doi:10.1074/jbc.273.40.25804
- Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5(5):405–414. doi:10.1038/nn835
- Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev. 2006;86(3):1009–1031. doi:10.1152/physrev.00049.2005
- Pape K, Tamouza R, Leboyer M, Zipp F. Immunoneuropsychiatry - novel perspectives on brain disorders. Nat Rev Neurol. 2019;15(6):317–328. doi:10.1038/s41582-019-0174-4